ENDOGENOUS-TISSUE PLASMINOGEN-ACTIVATOR AND PLATELET REACTIVITY AS RISK-FACTORS FOR REOCCLUSION AFTER RECANALIZATION OF CHRONIC CORONARY OCCLUSIONS

被引:0
作者
TERRES, W
LUND, GK
HUBNER, A
EHLERT, A
REUTER, H
HAMM, CW
机构
[1] UNIV HAMBURG,HOSP EPPENDORF,MED CLIN,DEPT CARDIOL,W-2000 HAMBURG 13,GERMANY
[2] UNIV HAMBURG,HOSP EPPENDORF,DEPT COAGULAT DISORDERS,W-2000 HAMBURG 13,GERMANY
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1150 / 1150
页数:1
相关论文
共 50 条
  • [21] LONG-TERM MAINTENANCE INFUSION OF RECOMBINANT DOUBLE CHAIN TISSUE PLASMINOGEN-ACTIVATOR - PREVENTION OF REOCCLUSION AFTER CORONARY THROMBOLYSIS
    MCKEE, PA
    CLINICAL RESEARCH, 1987, 35 (03): : A573 - A573
  • [22] Can reocclusion after recanalization of chronic total coronary occlusions be prevented by prolonged subcutaneous Heparin treatment?
    Sievert, H
    Heine, O
    Utech, A
    Schulze, R
    CIRCULATION, 1997, 96 (08) : 1488 - 1488
  • [23] Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke
    Rubiera, M
    Alvarez-Sabín, J
    Ribo, M
    Montaner, J
    Santamarina, E
    Arenillas, JF
    Huertas, R
    Delgado, P
    Purroy, F
    Molina, CA
    STROKE, 2005, 36 (07) : 1452 - 1456
  • [24] INTRACRANIAL HEMORRHAGE AFTER USE OF TISSUE PLASMINOGEN-ACTIVATOR FOR CORONARY THROMBOLYSIS
    KASE, CS
    ONEAL, AM
    FISHER, M
    GIRGIS, GN
    ORDIA, JI
    ANNALS OF INTERNAL MEDICINE, 1990, 112 (01) : 17 - 21
  • [25] ENDOGENOUS TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND RISK OF MYOCARDIAL-INFARCTION
    RIDKER, PM
    VAUGHAN, DE
    STAMPFER, MJ
    MANSON, JE
    HENNEKENS, CH
    LANCET, 1993, 341 (8854) : 1165 - 1168
  • [26] ROLE OF THROMBIN AND THROMBOXANE-A2 IN REOCCLUSION FOLLOWING CORONARY THROMBOLYSIS WITH TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    FITZGERALD, DJ
    FITZGERALD, GA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (19) : 7585 - 7589
  • [27] NONINVASIVE PREDICTION OF INFARCT VESSEL RECANALIZATION STATUS AFTER INTRAVENOUS TISSUE PLASMINOGEN-ACTIVATOR OR STREPTOKINASE
    KIRCHER, B
    TOPOL, EJ
    SCHORK, MA
    KLINE, E
    PITT, B
    ONEILL, WW
    CLINICAL RESEARCH, 1986, 34 (02): : A315 - A315
  • [28] PLATELET AND VASCULAR FUNCTION DURING CORONARY THROMBOLYSIS WITH TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    KERINS, DM
    ROY, L
    FITZGERALD, GA
    FITZGERALD, DJ
    CIRCULATION, 1989, 80 (06) : 1718 - 1725
  • [29] TISSUE PLASMINOGEN-ACTIVATOR AND OTHER RISK-FACTORS AS PREDICTORS OF CARDIOVASCULAR EVENTS IN PATIENTS WITH SEVERE ANGINA-PECTORIS
    JANSSON, JH
    NILSSON, TK
    OLOFSSON, BO
    EUROPEAN HEART JOURNAL, 1991, 12 (02) : 157 - 161
  • [30] HEMOSTATIC VARIABLES IN JAPANESE AND CAUCASIAN MEN - TISSUE PLASMINOGEN-ACTIVATOR, ANTITHROMBIN-III, AND PROTEIN-C AND THEIR RELATIONS TO CORONARY RISK-FACTORS
    ISO, H
    FOLSOM, AR
    WU, KK
    FINCH, A
    SATO, S
    MUNGER, RG
    SHIMAMOTO, T
    TERAO, A
    KOMACHI, Y
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1990, 132 (01) : 41 - 46